Abstract
Purpose
The study aimed to determine whether patients are receiving adequate counselling about elective bowel resection and timely surgery for inflammatory bowel disease (IBD).
Methods
Patients with IBD who underwent an elective bowel resection in a tertiary referral centre between April 2012 and Dec 2014 were identified from a prospective database. Patients under the age of 16 years were excluded from the study. Patients were contacted over the phone to complete a questionnaire regarding their perspective on their surgery, including the consultations that took place, preparedness and timing of surgery, as well as patient attitude towards bowel resection and satisfaction with post-operative outcomes. Demographic details were recorded.
Results
Thirty-one patients participated in the study. Twenty-one (68%) patients were diagnosed with Crohn’s disease, nine (29%) were diagnosed with ulcerative colitis, and one (3%) had indeterminate colitis. Twenty-seven (87%) patients reported that the timing of the initial consultation regarding the option of bowel resection was appropriate. Twenty-five (81%) patients felt prepared after a consultation with the surgical team with regard to perioperative issues and potential complications. Fourteen (45%) patients reported that the timing of bowel resection was appropriate, while 15 (48%) reported that it should have been earlier. A significant improvement in patient’s pre- and post-operative attitudes towards bowel resection was demonstrated (p = 0.004). Thirty (97%) patients were either happy or very happy with their results and symptom improvement post-bowel resection.
Conclusion
Most patients are receiving adequate counselling about elective bowel resection for IBD, although there is room for improvement for preoperative education and optimising timing of surgery.
Similar content being viewed by others
References
Burger D, Travis S (2011) Conventional medical management of inflammatory bowel disease. Gastroenterology 140(6):1827–1837 e1822. https://doi.org/10.1053/j.gastro.2011.02.045
Stuck AE, Minder CE, Frey FJ (1989) Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 11(6):954–963. https://doi.org/10.1093/clinids/11.6.954
Blomqvist P, Feltelius N, Lofberg R, Ekbom A (2001) A 10-year survey of inflammatory bowel diseases-drug therapy, costs and adverse reactions. Aliment Pharmacol Ther 15(4):475–481. https://doi.org/10.1046/j.1365-2036.2001.00942.x
Warman JI, Korelitz BI, Fleisher MR, Janardhanam R (2003) Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis. J Clin Gastroenterol 37(3):220–225. https://doi.org/10.1097/00004836-200309000-00006
Colombel JF, Loftus EV Jr, Tremaine WJ, Egan LJ, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ (2004) The safety profile of infliximab in patients with Crohn’s disease: the Mayo clinic experience in 500 patients. Gastroenterology 126(1):19–31. https://doi.org/10.1053/j.gastro.2003.10.047
Thirlby RC, Land JC, Fenster LF, Lonborg R (1998) Effect of surgery on health-related quality of life in patients with inflammatory bowel disease: a prospective study. Arch Surg 133(8):826–832
Sagar PM, Lewis W, Holdsworth PJ, Johnston D, Mitchell C, MacFie J (1993) Quality of life after restorative proctocolectomy with a pelvic ileal reservoir compares favorably with that of patients with medically treated colitis. Dis Colon Rectum 36(6):584–592. https://doi.org/10.1007/BF02049866
Tillinger W, Mittermaier C, Lochs H, Moser G (1999) Health-related quality of life in patients with Crohn's disease: influence of surgical operation--a prospective trial. Dig Dis Sci 44(5):932–938. https://doi.org/10.1023/A:1026600428484
Meyers S, Walfish JS, Sachar DB, Greenstein AJ, Hill AG, Janowitz HD (1980) Quality of life after surgery for Crohn’s disease: a psychosocial survey. Gastroenterology 78(1):1–6
McLeod RS, Baxter NN (1998) Quality of life of patients with inflammatory bowel disease after surgery. World J Surg 22(4):375–381. https://doi.org/10.1007/s002689900400
Hulten L (1988) Surgical treatment of Crohn’s disease of the small bowel or ileocecum. World J Surg 12(2):180–185. https://doi.org/10.1007/BF01658051
Solomon MJ, Pager CK, Keshava A, Findlay M, Butow P, Salkeld GP, Roberts R (2003) What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancer. Dis Colon Rectum 46(10):1351–1357. https://doi.org/10.1097/01.DCR.0000084432.45536.83
Suarez-Almazor ME, Conner-Spady B, Kendall CJ, Russell AS, Skeith K (2001) Lack of congruence in the ratings of patients’ health status by patients and their physicians. Med Decis Mak 21(2):113–121. https://doi.org/10.1177/02729890122062361
Bruera E, Willey JS, Palmer JL, Rosales M (2002) Treatment decisions for breast carcinoma: patient preferences and physician perceptions. Cancer 94(7):2076–2080. https://doi.org/10.1002/cncr.10393
Byrne CM, Solomon MJ, Young JM, Selby W, Harrison JD (2007) Patient preferences between surgical and medical treatment in Crohn’s disease. Dis Colon Rectum 50(5):586–597. https://doi.org/10.1007/s10350-006-0847-0
Shariff U, Narula H, Speake W, Brown S (2009) Terminal ileal Crohn’s disease: conservative surgeon and aggressive physician? Color Dis 11(5):522–523. https://doi.org/10.1111/j.1463-1318.2009.01820.x
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
ESM 1
(DOCX 29 kb).
Rights and permissions
About this article
Cite this article
Mui, M., An, V., Lovell, J. et al. Patients’ perspective on bowel resection for inflammatory bowel disease. Int J Colorectal Dis 33, 219–222 (2018). https://doi.org/10.1007/s00384-017-2941-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-017-2941-2